您的当前位置:首页 > 行业数据 > CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下
图片属性
图片格式:PNG 图片大小:187KB 图片尺寸:1735*908
同报告图片
 / 4
CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下_第1页
fCDoja/niakgICAgICAgICAgICAgICB8IOW5tOWMluWkjeWPkeasoeaVsCAoQVJSKSB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tfAp8IE9jcmVsaXp1bWFiICAgICAgfCAwLjE1ICAgICAgICAgICAgIHwKfCBPZmF0dW11bWFiICAgICAgIHwgMC4xMCAgICAgICAgICAgICB8CnwgVWJsaXR1eGltYWIgICAgICB8IDAuMTAgICAgICAgICAgICAgfAp8IEFsZW10dXp1bWFiICjmsrvnlpcpIHwgMC4yNSAgICAgICAgICAgIHwKfCBPemFuaW1vZCAgICAgICAgfCAwLjIwICAgICAgICAgICAgIHwKfCBTaXBvbmltb2QgICAgICAgIHwgMC4yMCAgICAgICAgICAgICB8CnwgRmluZ29saW1vZCAgICAgICB8IDAuMTUgICAgICAgICAgICAgfAp8IFBvbmF0aW5pYiAgICAgICAgfCAwLjIwICAgICAgICAgICAgIHwKfCDlr4zpqazphbjkuoznlLLpha8gICAgICAgfCAwLjE1ICAgICAgICAgICAgIHwKfCDnibnnq4vmsJ/og7ogICAgICAgICAgfCAwLjMwICAgICAgICAgICAgIHwKfCDogZrkuZnkuozphofljJbph43nu4TlubLmibDntKDOsi0xYSB8IDAuMjUgICAgICAgICAgIHwKfCBUb2ZhY2l0aW5pYiAgICAgIHwgMC4xMCAgICAgICAgICAgICB8CnwgRmVuZWJydXRpbmliICAgICB8IDAuMDUgICAgICAgICAgICAgfAp8IEV2b2JydXRpbmliICAgICAgfCAwLjEwICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWQhOacn+aWh+eMruOAgUluc2lnaHTjgIHlvIDmupDor4HliLjnoJTnqbbmiYAg5rOo77yaRmluZ29saW1vZOOAgeeJueeri+awn+iDuuS4juiBmuS5meS6jOmGh+WMlumHjee7hOW5suaJsOe0oM6yLTFh
CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下_第2页
CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下_第3页
CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下_第4页
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
CD20单抗、BTK抑制剂已将ARR率降低到平均0.15以下_第5页
所属报告: 生物制品行业深度报告:多发性硬化百亿美金市场BTKi发展前景广阔-250730(21页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠